Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Abildgaard

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Blood|May 1, 1987
Type IIA von Willebrand disease with apparent recessive inheritanceA Asakura, J Harrison, E Gomperts, et al.
Veterinary Pathology|January 1, 1978
Plasmodium knowlesi malaria in the Rhesus monkeyW L Spangler, D Gribble, C Abildgaard, et al.
The American Journal of Tropical Medicine and Hygiene|May 1, 1975
Simian hemorrhagic fever: Studies of coagulation and pathologyC Abildgaard, J Harrison, C Espana, et al.
Thrombosis Research|April 15, 1985
Assessment of thrombogenicity of prothrombin complex concentrates in a porcine modelJ Harrison, C Abildgaard, J Lazerson, et al.
The American Journal of Tropical Medicine and Hygiene|September 1, 1975
Simian Plasmodium knowlesi malaria: studies of coagulation and pathologyC Abildgaard, J Harrison, S DeNardo, et al.
Pediatrics|April 1, 1979
Effect of heparinization of fluids infused through an umbilical artery catheter on catheter patency and frequency of complicationsK Rajani, B W Goetzman, R P Wennberg, et al.
Lancet (London, England)|August 21, 1993
Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIIIJ Addiego, C Kasper, C Abildgaard, et al.
Journal of Thrombosis and Haemostasis : JTH|April 23, 2004
Human recombinant DNA-derived antihemophilic factor in the treatment of previously untreated patients with hemophilia A: final report on a hallmark clinical investigationJ Lusher, C Abildgaard, S Arkin, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1993
Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safetyS W Herring, C Abildgaard, K T Shitanishi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 3, 2000
Safety and efficacy of solvent/detergent-treated antihaemophilic factor with an added 80 degrees C terminal dry heat treatment in patients with haemophilia AJ S Powell, M Bush, J Harrison, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Blood|May 1, 1987
Type IIA von Willebrand disease with apparent recessive inheritanceA Asakura, J Harrison, E Gomperts, et al.
Veterinary Pathology|January 1, 1978
Plasmodium knowlesi malaria in the Rhesus monkeyW L Spangler, D Gribble, C Abildgaard, et al.
The American Journal of Tropical Medicine and Hygiene|May 1, 1975
Simian hemorrhagic fever: Studies of coagulation and pathologyC Abildgaard, J Harrison, C Espana, et al.
Thrombosis Research|April 15, 1985
Assessment of thrombogenicity of prothrombin complex concentrates in a porcine modelJ Harrison, C Abildgaard, J Lazerson, et al.
The American Journal of Tropical Medicine and Hygiene|September 1, 1975
Simian Plasmodium knowlesi malaria: studies of coagulation and pathologyC Abildgaard, J Harrison, S DeNardo, et al.
Pediatrics|April 1, 1979
Effect of heparinization of fluids infused through an umbilical artery catheter on catheter patency and frequency of complicationsK Rajani, B W Goetzman, R P Wennberg, et al.
Lancet (London, England)|August 21, 1993
Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIIIJ Addiego, C Kasper, C Abildgaard, et al.
Journal of Thrombosis and Haemostasis : JTH|April 23, 2004
Human recombinant DNA-derived antihemophilic factor in the treatment of previously untreated patients with hemophilia A: final report on a hallmark clinical investigationJ Lusher, C Abildgaard, S Arkin, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1993
Human coagulation factor IX: assessment of thrombogenicity in animal models and viral safetyS W Herring, C Abildgaard, K T Shitanishi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 3, 2000
Safety and efficacy of solvent/detergent-treated antihaemophilic factor with an added 80 degrees C terminal dry heat treatment in patients with haemophilia AJ S Powell, M Bush, J Harrison, et al.
Pageof 1